Sandbox: differentialdx maria: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align=center | |||
!style="padding: 5px 5px; background: #4479BA; font-weight: bold; text-align:center;" colspan="3"|{{fontcolor|#FFF|''Classification: Mucoepidermoid Carcinomas'' <br><SMALL>Adapted from Radiopedia <ref name="radiowiki"> Mucoepidermoid carcinoma. Radiopedia. Dr Frank Gailliard. http://radiopaedia.org/articles/mucoepidermoid-carcinoma-of-salivary-glands Accessed on February 17, 2016 </ref></SMALL>}} | |||
|valign=top| | |||
|+ | |||
|- | |||
|style="padding: 0 5px; background: #DCDCDC" rowspan="2"|{{fontcolor|#000|'''Salivary gland-confined carcinomas'''}} | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Major salivary glands (50%) | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Parotid gland (40%) | |||
*Submandibular gland (7%) | |||
*Sublingual gland (3%) | |||
|- | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Minor salivary glands (50%) | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Palate (most common) | |||
*Retromolar area | |||
*Floor of the mouth | |||
*Buccal mucosa | |||
*Lip | |||
*Tongue | |||
|- | |||
|style="padding: 0 5px; background: #DCDCDC" |{{fontcolor|#000|'''Other organ mucoepidermoid carcinomas'''}} | |||
|style="padding: 5px 5px; background: #F5F5F5;" colspan="2"| | |||
*Thyroid | |||
*Lung | |||
|} | |||
{|style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align=center | |||
!style="padding: 5px 5px; background: #4479BA; font-weight: bold; text-align:center;" colspan="3"|{{fontcolor|#FFF|''WHO histological classification system'' <br><SMALL>Adapted from WHO/IARC (2006) <ref name="radiowiki"> Tumors of the Lung. IARC/WHO https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-chap1.pdf Accessed on February 22, 2016 </ref></SMALL>}} | |||
|valign=top| | |||
|+ | |||
|- | |||
| style="background: #4479BA; width: 300px;"|{{fontcolor|#FFF|''' Main types'''}} | |||
| style="background: #4479BA; width: 300px;"|{{fontcolor|#FFF|''' Subtypes'''}} | |||
| style="background: #4479BA; width: 300px;"|{{fontcolor|#FFF|''' Prevalence'''}} | |||
|- | |||
|style="padding: 0 5px; background: #DCDCDC"| Adenocarcinoma | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Adenocarcinoma, mixed | |||
*Acinar adenocarcinoma | |||
*Papillary adenocarcinoma | |||
*Bronchioloalveolar carcinoma | |||
*Nonmucinous | |||
*Mucinous | |||
*Mixed nonmucinous and mucinous or indeterminate | |||
*Solid adenocarcinoma with mucin production | |||
*Fetal adenocarcinoma | |||
*Mucinous (“colloid”) carcinoma | |||
*Mucinous cystadenocarcinoma | |||
*Signet ring adenocarcinoma | |||
*Clear cell adenocarcinoma | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*40% of lung cancers | |||
|- | |||
|style="padding: 0 5px; background: #DCDCDC"| Squamous cell carcinoma | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Papillary | |||
*Clear cell | |||
*Small cell | |||
*Basaloid | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*25% of lung cancers | |||
|- | |||
|style="padding: 0 5px; background: #DCDCDC"| Large cell carcinoma | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Large cell neuroendocrine carcinoma | |||
*Basaloid carcinoma | |||
*Lymphoepithelioma-like carcinoma | |||
*Clear cell carcinoma | |||
*Large cell carcinoma with rhabdoid phenotype | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*10% of lung cancer | |||
|- | |||
|style="background: #4479BA; width: 100px; text-align:center;" colspan="3"|{{fontcolor|#FFF|'''Less common types'''}} | |||
|- | |||
|style="padding: 0 5px; background: #DCDCDC" | Adenosquamous carcinoma | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*No subtypes | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Less than 5% | |||
|- | |||
|style="padding: 0 5px; background: #DCDCDC" | Sarcomatoid carcinoma | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Pleomorphic carcinoma | |||
*Spindle cell carcinoma | |||
*Giant cell carcinoma | |||
*Carcinosarcoma | |||
*Pulmonary blastoma | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Less than 5% | |||
|- | |||
|style="padding: 0 5px; background: #DCDCDC" | Carcinoid tumor | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Typical carcinoid | |||
*Atypical carcinoid | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Less than 5% | |||
|- | |||
|style="padding: 0 5px; background: #DCDCDC" | Salivary gland tumor | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Mucoepidermoid carcinoma | |||
*Adenoid cystic carcinoma | |||
*Epithelial-myoepithelial carcinoma | |||
|style="padding: 5px 5px; background: #F5F5F5;"| | |||
*Less than 5% | |||
|} | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align=center | {| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align=center |
Revision as of 18:13, 22 February 2016
Classification: Mucoepidermoid Carcinomas Adapted from Radiopedia [1] |
|||
---|---|---|---|
Salivary gland-confined carcinomas |
|
| |
|
| ||
Other organ mucoepidermoid carcinomas |
|
WHO histological classification system Adapted from WHO/IARC (2006) [1] |
|||
---|---|---|---|
Main types | Subtypes | Prevalence | |
Adenocarcinoma |
|
| |
Squamous cell carcinoma |
|
| |
Large cell carcinoma |
|
| |
Less common types | |||
Adenosquamous carcinoma |
|
| |
Sarcomatoid carcinoma |
|
| |
Carcinoid tumor |
|
| |
Salivary gland tumor |
|
|
Genes | Presence in non small cell-lung cancers |
---|---|
EGFR |
|
KRAS |
|
ALK |
|
HER2 |
|
BRAF |
|
ROS-1 |
|
Classification | ||
---|---|---|
Salivary gland-confined carcinomas |
|
|
|
| |
Other organ mucoepidermoid carcinomas |
|
Mucoepidermoid carcinoma staging | |
---|---|
Tumor |
|
| |
| |
| |
| |
Nodes |
|
| |
| |
| |
| |
Overall stage |
|
| |
| |
| |
| |
|
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Benign mixed tumor | Painless parotid swelling and facial deformity | In benign mixed tumor , differentiating features include: histopathological findings |
Warthin tumor | Painless swelling and facial deformity | In warthin tumor differentiating features include: multicentric presentation (20%) and are usually small (1-4 cm), highly associated with smoking |
Adenoid cystic carcinoma | Swelling on salivary gland and facial deformity | In adenoid cystic carcinoma, differentiating features include: tendency for perineural extension, distribution, and mainly occur in relation to the airways |
Metastasis | Painless swelling and facial deformity | In metastasis, differentiating features include: primary tumor origin, and histopathological findings. |
Type of tumor | Age | Location | Histological features | Imaging features | Origin | Bone/Cartilage |
---|---|---|---|---|---|---|
Osteoma | 40-50 years | Skull bones | Matured lamellar bone | Sclerotic | Benign | Bone |
Osteoid osteoma | 10-20 years | Short and long bone diaphysis | Osteiod outlined by osteoblasts, incorporated in a fibrous stroma | Sclerotic | Benign | Bone |
Osteosarcoma | 11-40 years | Long bones metaphysis | Osteoid and bone formed of malignant osteoblasts and fibroblasts | Sclerotic | Malignant | Bone |
Chondroma | 30-60 years | Small tubular bones of the hands and feet | Maturated hyaline cartilage (enchondroma/ecchondroma), preserving lobulation | Well-defined | Malignant | Cartilage |
Chondrosarcoma | 30-60 years | Long bones metaphysic, axial skeleton | Immature cartilage, no preserving lobulation, cells arranged in groups of two or four, with atypia and mitosis | Well-defined | Malignant | Cartilage |
Ewing sarcoma | 5-25 years | Long bones diaphysis | Small, round, undifferentiated cells, no stroma, a lot of capillary arrangement. | Ill-defined | Malignant | Bone |
Giant cell tumor | 20-40 years | Knee | Multinucleated giant cells, fusiform cells, mononuclear cells. | Well-defined | Malignant | Bone |
Metastases | 50-90 years | No site predilection | Frequently adenocarcinomas. Metastases can be blastic or lytic depending on the tumor origin | Sclerotic | Malignant | Bone |
Stage | Description |
---|---|
I |
|
II |
|
III |
|
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Enchondroma |
|
|
Chondroblastoma |
|
|
Periosteal chondroma |
|
|
Chondromyxoid fibroma |
|
|
Type of osteochondroma | Features |
---|---|
Solitary osteochondroma |
|
Multiple osteochondromas (hereditary) |
|
Genes implicated in HNPCC | Frequency of mutations in HNPCC families | Locus |
---|---|---|
MSH2 | approximately 60% | 2p22 |
MLH1 | approximately 30% | 3p21 |
MSH6 | 7-10% | 2p16 |
PMS2 | relatively infrequent | 7p22 |
PMS1 | case report | 2q31-q33 |
TGFBR2 | case report | 3p22 |
MLH3 | disputed | 14q24.3 |
Type of osteoid osteoma | Characteristics |
---|---|
Intracortical | Dense sclerosis around the nidus |
Periosteal | Periosteal reaction |
Cancellous (medullary) | Produces very little reactive bone |
Subarticular | Simulates arthritis as it produces synovial reactions |
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Osteoblastoma |
|
|
Brodie abscess |
|
|
Osteosarcoma |
|
|
Enostosis |
|
|
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Fibrous dysplasia |
|
|
Osteoblastoma |
|
|
Adamantinomas |
|
|
Chronic sinusitis |
|
|
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Cardiac tamponade |
|
|
Chronic obstructive pulmonary disease |
|
|
Mediastinitis |
|
|
Pneumonia |
|
|
Acute respiratory distress syndrome |
|
|
Syphilis |
|
|
Differential Diagnosis | Similar Features | Differentiating Features |
---|---|---|
Familial adenomatous polyposis (FAP) |
|
|
Juvenile polyposis |
|
|
Cowden syndrome |
|
|
- ↑ 1.0 1.1 1.2 Mucoepidermoid carcinoma. Radiopedia. Dr Frank Gailliard. http://radiopaedia.org/articles/mucoepidermoid-carcinoma-of-salivary-glands Accessed on February 17, 2016
- ↑ AJCC System for Staging of Benign and Malignant Salivary Gland Tumors. AJCC Accessed on February 18, 2016